ConductScience.org, home

Paper17513808

Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type.

Zighelboim I and 6 others. J Clin Oncol, 2007. Cited by 175 papers, by iCite.

Cite this record

ConductScience Library. Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type. Papers, record 17513808. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17513808

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type.
PubMed
Journal
J Clin Oncol
PubMed
Year
2007
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
175
iCite
Relative citation ratio, by iCite
3.41
iCite
Revised in PubMed
2025-10-22
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zighelboim IIsrael
2Goodfellow PJPaul J
3Gao FFeng
4Gibb RKRandall K
5Powell MAMatthew A
6Rader JSJanet S
7Mutch DGDavid G

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adaptor Proteins, Signal TransducingMajor topic
Carcinoma, EndometrioidMajor topic
DNA MethylationMajor topic
Endometrial NeoplasmsMajor topic
Epigenesis, GeneticMajor topic
Microsatellite InstabilityMajor topic
Nuclear ProteinsMajor topic
Cohort Studies
DNA Repair
Female
Humans
Microsatellite Repeats
Middle Aged
MutL Protein Homolog 1
MutS Homolog 2 Protein
Polymerase Chain Reaction
Prospective Studies

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 CA91842NCI NIH HHSUnited StatesP30CA091842PubMed and NIHNIH RePORTER
R01 CA71754NCI NIH HHSUnited StatesR01CA071754PubMed and NIHNIH RePORTER

Download CSV of grants

Cited by95

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 175 citations.

PMIDTitleJournalYearIn PapersSource
41976325Feasibility of TP53-Mutated ctDNA Monitoring in High-Grade Endometrial Cancer Using Routine NGS.Cancers (Basel)2026https://conductscience.org/library/papers/41976325PubMed
41918736Does immunotherapy hold great promise in endometrial cancer care?Front Immunol2026https://conductscience.org/library/papers/41918736PubMed
40878396The relationship between histopathological data and molecular alterations with oncological outcomes in endometrioid-type endometrial cancers and a novel POLE mutation.J Gynecol Oncol2026https://conductscience.org/library/papers/40878396PubMed
40657367Mismatch Repair Protein Deficiency and Its Relationship with Clinicopathological Factors in Endometrial Cancer: A Retrospective Study.J Cancer2025https://conductscience.org/library/papers/40657367PubMed
40149367Trends in Endometrial Cancer Incidence Among Premenopausal and Postmenopausal Women in the United States Between 2001 and 2021.Cancers (Basel)2025https://conductscience.org/library/papers/40149367PubMed
40141259MiR-205-5p and MiR-222-3p as Potential Biomarkers of Endometrial Cancer.Int J Mol Sci2025https://conductscience.org/library/papers/40141259PubMed
39301379Clinicopathological Significance of Defective DNA Mismatch Repair in Endometrial Carcinoma: A Single-Center Study From Bahrain.Cureus2024https://conductscience.org/library/papers/39301379PubMed
39220299Molecular classification of endometrial cancer: preliminary experience from a single Portuguese academic center.Pathol Oncol Res2024https://conductscience.org/library/papers/39220299PubMed
39020532Prognostic implications of immunohistochemistry in patients with endometrial cancer.Rom J Morphol Embryol2024https://conductscience.org/library/papers/39020532PubMed
38539494
Biomarkers in the Diagnosis of Endometrial Precancers. Molecular Characteristics, Candidate Immunohistochemical Markers, and Promising Results of Three-Marker Panel: Current Status and Future Directions.
Cancers (Basel)2024https://conductscience.org/library/papers/38539494PubMed
38318760Role of INPP4B in the proliferation, migration, invasion, and survival of human endometrial cancer cells.Histol Histopathol2024https://conductscience.org/library/papers/38318760PubMed
37765210Targeting DNA Damage Repair and Immune Checkpoint Proteins for Optimizing the Treatment of Endometrial Cancer.Pharmaceutics2023https://conductscience.org/library/papers/37765210PubMed
37509300Retrospective Analysis of the Correlation of MSI-h/dMMR Status and Response to Therapy for Endometrial Cancer: RAME Study, a Multicenter Experience.Cancers (Basel)2023https://conductscience.org/library/papers/37509300PubMed
37422672Clear cell endometrial carcinoma with high microsatellite instability in a complicated pregnancy: a case report.J Med Case Rep2023https://conductscience.org/library/papers/37422672PubMed
37190216Microsatellite Instability: A Review of Molecular Epidemiology and Implications for Immune Checkpoint Inhibitor Therapy.Cancers (Basel)2023https://conductscience.org/library/papers/37190216PubMed
37146405Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease.EBioMedicine2023https://conductscience.org/library/papers/37146405PubMed
36979434Novel Insights into Molecular Mechanisms of Endometrial Diseases.Biomolecules2023https://conductscience.org/library/papers/36979434PubMed
36833105Role of Genomic and Molecular Biology in the Modulation of the Treatment of Endometrial Cancer: Narrative Review and Perspectives.Healthcare (Basel)2023https://conductscience.org/library/papers/36833105PubMed
36377723Complete pathological response following chemotherapy and radiotherapy in two cases of advanced anaplastic thyroid carcinoma.Eur Thyroid J2023https://conductscience.org/library/papers/36377723PubMed
36348114Epigenetic-Mediated Regulation of Gene Expression for Biological Control and Cancer: Cell and Tissue Structure, Function, and Phenotype.Results Probl Cell Differ2022https://conductscience.org/library/papers/36348114PubMed

See all 95 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
MLH14292PubTator's text mininghttps://conductscience.org/library/genes/4292NCBI Gene
MSH24436PubTator's text mininghttps://conductscience.org/library/genes/4436NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17513808

GET https://conductscience.org/api/papers/v1/17513808/cited_by?page=2